Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 0 percent. This is a 47.83 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $84.084 million which beat the analyst consensus estimate of $81.603 million by 3.04 percent. This is a 21.18 percent increase over sales of $69.387 million the same period last year.